Marksans Pharma Ltd announced that through its wholly owned subsidiary Marksans Pharma Inc, it has purchased 100% stake in US-based generic formulation maker Time-Cap Laboratories Inc for an undisclosed amount. The acquisition is said to boost ... Pharmacy Choice, 2 days ago
Marksans Pharma acquires New York-based Time-Cap Laboratories - VC Circle, 4 days ago
Marksans Pharm acquires 100% stake in Time-Cap Laboratories - Individual.com, 5 days ago
More from: ADVFN UK, Finalaya.com...and 2 other sources
New Delhi: Reliance Industries Ltd (RIL), HDFC Bank and Dr Reddy's Laboratories are the only three Indian firms to figure in Barclays top 111 stock picks from across the world for 2015. In its Global Top Picks report, Barclays has said more than six ...Deccan Chronicle, 4 days ago RIL, HDFC Bank, DRL in Barclays' global stock picks Business Standard, 5 days ago Reliance Industries, HDFC Bank, Dr Reddy's Lab In Barclays'Global Stock Picks Silicon India, 4 days ago Results watch: Dr Reddy's Laboratories, Motherson Sumi Systems in focus India Infoline, 1 month ago
'Divi's Laboratories Ltd. is a 'BUY' call with a target of Rs 1,950 and a stop loss of Rs 1,850'Economic Times, 4 days ago Buy Dr Reddy's Labs with a target of Rs 3,591: Sandeep Wagle Economic Times, 6 days ago Buy Dr Reddy's Laboratories with a target of Rs 3,540: Mitesh Thacker Economic Times, 1 month ago
Caplin Point Laboratories Ltd listed for second consecutive year on Forbes Asia's "200 Best Under a Billion"
Posted On: 2015-07-02 19:26:30 Caplin Point Laboratories Ltd has been selcted under Forbes Asia's "200 Best Under a Billion" for 2015. The company has been selected for the second consecutive year. The list has been published in the magazine's July ...Equity Bulls, 2 days ago DR REDDY LABORATORIES : Labs gets new brand identity 4 Traders, 3 days ago Zenotech Laboratories appoints Virendra Gunvantrai Bhatt as independent director Moneycontrol.com, 5 days ago Dr Reddys Laboratories Ltd clarifies on recall of Divalproex Equity Bulls, 4 days ago
HYDERABAD: Dr Reddy's Laboratories Ltd (DRL) has initiated a voluntary recall of some of the drugs from the US market. While Amlodipine Besylate and Atorvastatin Calcium tablets are being recalled since these were close to expiry, Divalproex ...New Indian Express, 5 days ago Indian drug maker recalls two medicines from US Prokerala, 6 days ago Tighter drug quality norms, price controls open route to M&A deals Domain-B, 5 days ago
European private-equity firm Cinven Ltd. is buying German medical laboratory operator Synlab for about €1.75 billion ($1.96 billion). Cinven will combine Synlab with France's Labco, which it acquired for €1.2 billion last month, according to ...Asian Hospital & Healthcare Management, 1 week ago
Posted On: 2015-06-30 21:45:30 JHS Svendgaard Laboratories Ltd Board to consider Dividend for 2014-15A meeting of the Audit Committee and Board of Directors of JHS Svendgaard Laboratories Ltd has been scheduled to be held on July 08, 2015, to ...Equity Bulls, 4 days ago Neuland Laboratories Ltd Fixes Book Closure for Dividend & 31st AGM Equity Bulls, 1 week ago JHS Svendgaard Laboratories board meeting on July 02, 2015 Moneycontrol.com, 1 week ago Chemo Pharma Laboratories' board meeting on May 28, 2015 Money Control, 1 month ago
Mumbai: Generic drugmaker Ranbaxy Laboratories Ltd has been sued in a district court in the United States for allegedly manipulating US Food and Drug Administration rules for years to keep rival generic drugs out of the market. Ranbaxy filed "grossly ...Sify, 1 month ago U.S. class action asserts Ranbaxy manipulated FDA rules Reuters, 1 month ago U.S. class action asserts India's Ranbaxy manipulated FDA rules Reuters, 1 month ago
More from: , First Post.com...and 1 other sources
Dr Reddy's Laboratories Ltd, India's second-largest drugmaker, expects domestic sales to grow nearly 20% this financial year, helped by the launch of nearly two dozen products, a senior executive said. The forecast tops one of 15% growth for the generic ...The Financial Chronicle, 2 months ago Dr Reddy's sees India sales growing 20 per cent on new product launches Economic Times, 2 months ago
Fujitsu Laboratories of Europe Ltd. and Fujitsu EMEIA have announced a strategic research collaboration agreement with the Foundation for Biomedical Research of San Carlos Clinical Hospital, or FIBHCSC. Fujitsu will be working closely with the ...Individual.com, 4 days ago
on your WebpageAdd Widget >Get your members hooked!